alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with pentylenetetrazole in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (38.46) | 18.2507 |
2000's | 5 (38.46) | 29.6817 |
2010's | 2 (15.38) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Klitgaard, H; Laudrup, P | 1 |
Donevan, SD; Rogawski, MA; Yamaguchi, S | 1 |
Chapman, AG; Chimirri, A; Constanti, A; De Sarro, A; De Sarro, G; Gitto, R; Giusti, P; Grasso, S; Libri, V; Quartarone, S; Zappalà, M | 1 |
Chimirri, A; Constanti, A; De Sarro, A; De Sarro, G; Gitto, R; Libri, V; Quartarone, S; Zappalà, M | 1 |
Baraldi, M; De Micheli, C; De Sarro, A; De Sarro, G; Grasso, S; Micale, N; Puia, G; Zappalà, M | 1 |
Baraldi, M; De Micheli, C; De Sarro, A; De Sarro, G; Grasso, S; Micale, N; Puja, G; Zappalà, M | 1 |
Bevacqua, F; Chimirri, A; De Sarro, A; De Sarro, G; Gitto, R; Quartarone, S; Rizzo, M; Zappalà, M | 1 |
Alvarado, R; Camacho-Arroyo, I; Manjarrez, J | 1 |
Rensing, N; Rothman, SM; Thio, LL; Weisenfeld, AE; Wong, M; Xu, L; Yamada, KA; Yang, XF; Zhang, HX | 1 |
Diano, S; Horvath, TL | 1 |
Aizenman, CD; Bell, MR; Deeg, KE; Lee, RH; Marsh-Armstrong, N; Mills, EA; Ruthazer, ES; Schwartz, N | 1 |
Banerjee, AG; Das, N; Shrivastava, SK | 1 |
Abulkhair, HS; Ahmed, HEA; Akl, EN; Bayoumi, AH; El-Adl, K; El-Morsy, A; El-Zoghbi, MS; Elmeligie, S; Ghiaty, A; Hassan, MH; Zayed, MF | 1 |
13 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and pentylenetetrazole
Article | Year |
---|---|
Metabotropic excitatory amino acid receptor agonists selectively potentiate behavioral effects induced by ionotropic excitatory amino acid receptor agonists in mice.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Cycloleucine; Drug Synergism; Injections, Intraventricular; Kainic Acid; Male; Mice; N-Methylaspartate; Neurotoxins; Pentylenetetrazole; Receptors, Glutamate; Seizures | 1993 |
Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models.
Topics: 4-Aminopyridine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Anticonvulsants; Benzodiazepines; Binding, Competitive; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Hindlimb; Kainic Acid; Male; Mice; Pentylenetetrazole; Quinoxalines; Receptors, AMPA; Receptors, Kainic Acid; Seizures | 1993 |
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
Topics: Acoustic Stimulation; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Benzodiazepinones; Convulsants; Mice; Mice, Inbred DBA; Pentylenetetrazole; Pyrrolidinones; Receptors, AMPA; Seizures | 1997 |
3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.
Topics: Acoustic Stimulation; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Benzodiazepines; Convulsants; Electroshock; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Guinea Pigs; In Vitro Techniques; Male; Mice; Mice, Inbred DBA; Motor Activity; Olfactory Pathways; Patch-Clamp Techniques; Pentylenetetrazole; Pyrrolidinones; Rats; Receptors, AMPA; Seizures; Structure-Activity Relationship; Thiones | 1998 |
Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Cells, Cultured; Convulsants; Drug Evaluation, Preclinical; Electroshock; Excitatory Amino Acid Antagonists; Kainic Acid; Male; Mice; Mice, Inbred DBA; Motor Activity; Neurons; Patch-Clamp Techniques; Pentylenetetrazole; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Seizures | 1999 |
Synthesis and anticonvulsant activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)-ones.
Topics: Acoustic Stimulation; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Cells, Cultured; Convulsants; Drug Evaluation, Preclinical; Electroshock; Excitatory Amino Acid Agonists; Isoxazoles; Kainic Acid; Mice; Mice, Inbred DBA; Neurons; Patch-Clamp Techniques; Pentylenetetrazole; Phthalazines; Propionates; Receptors, AMPA; Receptors, Kainic Acid; Seizures; Structure-Activity Relationship | 2000 |
Synthesis and evaluation of pharmacological and pharmacokinetic properties of 11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepin-3(2H)-ones.
Topics: Acoustic Stimulation; Allosteric Regulation; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Benzodiazepines; Chromatography, High Pressure Liquid; Electroshock; Excitatory Amino Acid Antagonists; Male; Mice; Mice, Inbred DBA; Motor Activity; Pentylenetetrazole; Pyrrolidinones; Receptors, AMPA; Seizures; Structure-Activity Relationship | 2000 |
Differential effects of NMDA antagonists microinjections into the nucleus reticularis pontis caudalis on seizures induced by pentylenetetrazol in the rat.
Topics: 2-Amino-5-phosphonovalerate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Dizocilpine Maleate; Electroencephalography; Excitatory Amino Acid Antagonists; Male; Microinjections; N-Methylaspartate; Pentylenetetrazole; Pons; Rats; Rats, Wistar; Reticular Formation; Seizures | 2001 |
Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents.
Topics: 4-Aminopyridine; Administration, Intranasal; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Convulsants; Hypothalamus; Janus Kinase 2; Leptin; Male; Mice; Mice, Knockout; Neurons; Pentylenetetrazole; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Leptin; Seizures; Synaptic Transmission | 2008 |
Anticonvulsant effects of leptin in epilepsy.
Topics: 4-Aminopyridine; Administration, Intranasal; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Convulsants; Hypothalamus; Janus Kinase 2; Leptin; Male; Mice; Mice, Knockout; Neurons; Pentylenetetrazole; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Leptin; Seizures; Synaptic Transmission | 2008 |
Neurodevelopmental effects of chronic exposure to elevated levels of pro-inflammatory cytokines in a developing visual system.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Avoidance Learning; Behavior, Animal; Convulsants; Cytokines; Dendrites; Electrophysiology; Excitatory Postsynaptic Potentials; GABA Antagonists; Interleukin-1beta; Interleukin-6; Larva; N-Methylaspartate; Nervous System; Neural Pathways; Neurons; Pentylenetetrazole; Retina; Seizures; Superior Colliculi; Synapses; Synaptic Transmission; Tectum Mesencephali; Time Factors; Tumor Necrosis Factor-alpha; Visual Pathways | 2010 |
Design, synthesis and pharmacological evaluation of N3 aryl/ heteroaryl substituted 2-((benzyloxy and phenylthio) methyl) 6,7- dimethoxyquinazolin-4(3H)-ones as potential anticonvulsant agents.
Topics: Alanine Transaminase; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Aspartate Aminotransferases; Convulsants; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Electroshock; Female; Injections, Intraventricular; Injections, Subcutaneous; Liver; Male; Mice; Motor Activity; Pentylenetetrazole; Quinazolinones; Rats; Rotarod Performance Test; Seizures; Structure-Activity Relationship | 2014 |
In vivo- and in silico-driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anticonvulsants; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Mice; Molecular Docking Simulation; Molecular Structure; Pentylenetetrazole; Quinoxalines; Seizures; Structure-Activity Relationship | 2021 |